lobbying_activities: 2422778

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2422778	bb865ecd-a3f1-4031-a24f-e6b6ca472ae8	Q1	TAUZIN STRATEGIC NETWORKS	400786367	TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)	2020	first_quarter	MMM	Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).	HOUSE OF REPRESENTATIVES,SENATE			0	0	2020-04-10T10:50:17.207000-04:00